Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy

Immune checkpoint inhibitors (ICIs) have made breakthrough progress in the treatment of various malignant tumors. However, only some patients receiving ICIs obtain long-lasting clinical effects, and some patients still do not achieve remission. Improving the treatment benefits of this part of the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaogang, Liu, Yu, Xiang, Jing, Wang, Yuntao, Wang, Qiqian, Xia, Jianling, Chen, Yunfei, Bai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344046/
https://www.ncbi.nlm.nih.gov/pubmed/34367132
http://dx.doi.org/10.3389/fimmu.2021.665002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344046/
https://www.ncbi.nlm.nih.gov/pubmed/34367132
http://dx.doi.org/10.3389/fimmu.2021.665002

Ejemplares similares